BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31760501)

  • 1. Characterizing the invasion of different breast cancer cell lines with distinct E-cadherin status in 3D using a microfluidic system.
    Eslami Amirabadi H; Tuerlings M; Hollestelle A; SahebAli S; Luttge R; van Donkelaar CC; Martens JWM; den Toonder JMJ
    Biomed Microdevices; 2019 Nov; 21(4):101. PubMed ID: 31760501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-cadherin promotor methylation and mutation are inversely related to motility capacity of breast cancer cells.
    van Horssen R; Hollestelle A; Rens JA; Eggermont AM; Schutte M; Ten Hagen TL
    Breast Cancer Res Treat; 2012 Nov; 136(2):365-77. PubMed ID: 23053649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characterization of E- and P-cadherin in invasive breast cancer cells.
    Sarrió D; Palacios J; Hergueta-Redondo M; Gómez-López G; Cano A; Moreno-Bueno G
    BMC Cancer; 2009 Mar; 9():74. PubMed ID: 19257890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
    Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
    Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and significance of Twist, estrogen receptor, and E-cadherin in human breast cancer cells and tissues.
    Tan R; Wang L; Song J; Li J; He T
    J Cancer Res Ther; 2017; 13(4):707-714. PubMed ID: 28901319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Noncoding RNA TCONS_00068220 Promotes Breast Cancer Progression by Regulating Epithelial-Mesenchymal Transition Marker E-Cadherin.
    Liu X; Tian X
    Med Sci Monit; 2021 Mar; 27():e929832. PubMed ID: 33716295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-544a Promotes Breast Cancer Cell Migration and Invasion Reducing Cadherin 1 Expression.
    Lu P; Gu Y; Li L; Wang F; Qiu X
    Oncol Res; 2016; 23(4):165-70. PubMed ID: 27053345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The number of polyploid giant cancer cells and epithelial-mesenchymal transition-related proteins are associated with invasion and metastasis in human breast cancer.
    Fei F; Zhang D; Yang Z; Wang S; Wang X; Wu Z; Wu Q; Zhang S
    J Exp Clin Cancer Res; 2015 Dec; 34():158. PubMed ID: 26702618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of wild-type and mutant E-cadherin on cell proliferation and responsiveness to the chemotherapeutic agents cisplatin, etoposide, and 5-fluorouracil.
    Fricke E; Hermannstädter C; Keller G; Fuchs M; Brunner I; Busch R; Höfler H; Becker KF; Luber B
    Oncology; 2004; 66(2):150-9. PubMed ID: 15138368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
    Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
    Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bacterial protein azurin impairs invasion and FAK/Src signaling in P-cadherin-overexpressing breast cancer cell models.
    Bernardes N; Ribeiro AS; Abreu S; Mota B; Matos RG; Arraiano CM; Seruca R; Paredes J; Fialho AM
    PLoS One; 2013; 8(7):e69023. PubMed ID: 23894398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel method to understand tumor cell invasion: integrating extracellular matrix mimicking layers in microfluidic chips by "selective curing".
    Eslami Amirabadi H; SahebAli S; Frimat JP; Luttge R; den Toonder JMJ
    Biomed Microdevices; 2017 Oct; 19(4):92. PubMed ID: 29038872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RY10-4 suppressed metastasis of MDA-MB-231 by stabilizing ECM and E-cadherin.
    Liu Z; Liu Z; Zhang X; Xue P; Zhang H
    Biomed Pharmacother; 2014 May; 68(4):439-45. PubMed ID: 24721328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition.
    Chao YL; Shepard CR; Wells A
    Mol Cancer; 2010 Jul; 9():179. PubMed ID: 20609236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alkyl-lysophospholipid 1-O-octadecyl-2-O-methyl- glycerophosphocholine induces invasion through episialin-mediated neutralization of E-cadherin in human mammary MCF-7 cells in vitro.
    Steelant WF; Goeman JL; Philippé J; Oomen LC; Hilkens J; Krzewinski-Recchi MA; Huet G; Van der Eycken J; Delannoy P; Bruyneel EA; Mareel MM
    Int J Cancer; 2001 May; 92(4):527-36. PubMed ID: 11304687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slug-upregulated miR-221 promotes breast cancer progression through suppressing E-cadherin expression.
    Pan Y; Li J; Zhang Y; Wang N; Liang H; Liu Y; Zhang CY; Zen K; Gu H
    Sci Rep; 2016 May; 6():25798. PubMed ID: 27174021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERalpha signaling through slug regulates E-cadherin and EMT.
    Ye Y; Xiao Y; Wang W; Yearsley K; Gao JX; Shetuni B; Barsky SH
    Oncogene; 2010 Mar; 29(10):1451-62. PubMed ID: 20101232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HS3ST2 modulates breast cancer cell invasiveness via MAP kinase- and Tcf4 (Tcf7l2)-dependent regulation of protease and cadherin expression.
    Vijaya Kumar A; Salem Gassar E; Spillmann D; Stock C; Sen YP; Zhang T; Van Kuppevelt TH; Hülsewig C; Koszlowski EO; Pavao MS; Ibrahim SA; Poeter M; Rescher U; Kiesel L; Koduru S; Yip GW; Götte M
    Int J Cancer; 2014 Dec; 135(11):2579-92. PubMed ID: 24752740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasion of interstitial matrix by a novel cell line from primary peritoneal carcinosarcoma, and by established ovarian carcinoma cell lines: role of cell-matrix adhesion molecules, proteinases, and E-cadherin expression.
    Kokenyesi R; Murray KP; Benshushan A; Huntley ED; Kao MS
    Gynecol Oncol; 2003 Apr; 89(1):60-72. PubMed ID: 12694655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells.
    Roger L; Jullien L; Gire V; Roux P
    J Cell Sci; 2010 Apr; 123(Pt 8):1295-305. PubMed ID: 20332115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.